SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000886163-22-000030
Filing Date
2022-02-28
Accepted
2022-02-28 17:27:37
Documents
93
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lgnd-20211231.htm   iXBRL 10-K 3230507
2 EX-10.37 lgnd_123121xexhibit1037.htm EX-10.37 732730
3 EX-10.39 exhibit1039_ligandpharmace.htm EX-10.39 715512
4 EX-21.1 lgnd_123121xexhibit211.htm EX-21.1 16920
5 EX-23.1 lgnd_123121xexhibit231.htm EX-23.1 4938
6 EX-31.1 lgnd_123121xexhibit311.htm EX-31.1 15729
7 EX-31.2 lgnd_123121xexhibit312.htm EX-31.2 15797
8 EX-32.1 lgnd_123121xexhibit321.htm EX-32.1 13381
14 image_0a.jpg GRAPHIC 185653
15 image_1a.jpg GRAPHIC 1043634
16 lgnd-20211231_g1.jpg GRAPHIC 21469
17 lgnd-20211231_g2.jpg GRAPHIC 513007
18 lgnd-20211231_g3.jpg GRAPHIC 137911
  Complete submission text file 0000886163-22-000030.txt   19136536

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20211231.xsd EX-101.SCH 74155
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20211231_cal.xml EX-101.CAL 137274
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20211231_def.xml EX-101.DEF 457623
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20211231_lab.xml EX-101.LAB 1094381
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20211231_pre.xml EX-101.PRE 709296
87 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20211231_htm.xml XML 2675988
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33093 | Film No.: 22691689
SIC: 2834 Pharmaceutical Preparations